These are stressful and uncertain times, as the world races to try to curtail the spread of the coronavirus and to develop a vaccine to prevent it.
While the crisis is overwhelmingly on our minds, cancer isn’t going away. Those currently dealing with cancer have no choice but to continue to deal with it in the best way possible right now.
In this post, I’m sharing links to a number of articles and sites that provide relevant information on cancer and coping with the COVID-19 pandemic. Continue reading
I remember how terrifying it was to hear the diagnosis of breast cancer. At the age of 35, I had to face a potentially life-threatening diagnosis, major surgery and chemotherapy after that.
When I read news articles about cancer research, I often find myself annoyed by the confusing way in which terminology about cancer and cancer research in used.
Two recent studies have come out with some interesting and important findings about exposures to endocrine disrupters and our risks for cancer.
I always come back from the San Antonio Breast Cancer Symposium overflowing with information and insights about the latest developments in breast cancer research.
Timely access to treatment is critical for individuals dealing with any number of medical conditions. Metastatic breast cancer is no exception.
Over the years, October has become a marketing opportunity for companies that splash pink on their products, suggesting to consumers that they’re helping the breast cancer cause by buying these products.
One of the stories that has stood out over the last few years in breast cancer treatment was the FDA’s approval in 2015 of the drug palbociclib (Ibrance) for treatment of hormone receptor-positive metastatic breast cancer.
I’m delighted to participate in the 
What are the best ideas for how we could prevent breast cancer in whole populations?